Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-04-18 Sale |
2023-04-19 6:07 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $36 | $360,000 | 169,416 (Direct) |
View |
| 2023-02-27 Sale(A) |
2023-04-19 6:01 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
2,984 | $49.55 | $147,854 | 179,416 (Direct) |
View |
| 2023-03-07 Sale |
2023-03-09 5:04 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $43.82 | $1,314,550 | 653,666 (Direct) |
View |
| 2023-02-28 Sale |
2023-03-01 6:07 pm |
HALOZYME THERAPEUTICS INC. | HALO | Henderson Jeffrey William Director |
20,000 | $48.11 | $962,200 | 39,045 (Direct) |
View |
| 2023-02-27 Sale |
2023-02-28 4:59 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $49.55 | $495,483 | 138,927 (Direct) |
View |
| 2023-02-16 Sale |
2023-02-21 7:05 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
2,878 | $49.26 | $141,770 | 233,165 (Direct) |
View |
| 2023-02-16 Sale |
2023-02-21 7:00 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
2,525 | $49.26 | $124,382 | 106,722 (Direct) |
View |
| 2023-02-16 Sale |
2023-02-21 6:59 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
11,061 | $49.26 | $544,865 | 957,552 (Direct) |
View |
| 2023-02-15 Sale |
2023-02-17 06:29 am |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $48.39 | $483,940 | 152,465 (Direct) |
View |
| 2023-02-07 Sale |
2023-02-09 5:44 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $51.01 | $1,530,150 | 707,177 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-19 5:07 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $51.3 | $1,539,149 | 797,177 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-18 7:07 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $50.46 | $504,590 | 143,137 (Direct) |
View |
| 2022-12-13 Sale |
2022-12-15 7:12 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $58.11 | $1,743,302 | 887,177 (Direct) |
View |
| 2022-12-13 Sale |
2022-12-13 6:09 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $58.67 | $586,675 | 153,137 (Direct) |
View |
| 2022-12-02 Sale |
2022-12-06 7:07 pm |
HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director |
30,000 | $56.88 | $1,706,550 | 105,189 (Direct) |
View |
| 2022-11-15 Sale |
2022-11-17 5:09 pm |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $53.39 | $1,601,626 | 977,177 (Direct) |
View |
| 2022-11-15 Sale |
2022-11-16 7:51 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
5,000 | $53.81 | $269,053 | 4,045 (Direct) |
View |
| 2022-11-15 Sale |
2022-11-16 7:25 pm |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $54.13 | $541,263 | 163,137 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-05 Option Award |
2023-05-09 6:24 pm |
2024-05-05 2033-05-05 |
HALOZYME THERAPEUTICS INC. | HALO | Miyashita Akiko Moni Director |
19,436 | $0 | 25,642 (Direct) |
View |
| 2023-05-05 Option Award |
2023-05-09 6:21 pm |
2024-05-05 2033-05-05 |
HALOZYME THERAPEUTICS INC. | HALO | MATSUI CONNIE Director |
19,436 | $0 | 198,375 (Direct) |
View |
| 2023-05-05 Option Award |
2023-05-09 6:19 pm |
2024-05-05 2033-05-05 |
HALOZYME THERAPEUTICS INC. | HALO | Henderson Jeffrey William Director |
19,436 | $0 | 58,481 (Direct) |
View |
| 2023-05-05 Option Award |
2023-05-09 6:16 pm |
2024-05-05 2033-05-05 |
HALOZYME THERAPEUTICS INC. | HALO | Duncan Barbara Gayle Director |
19,436 | $0 | 20,624 (Direct) |
View |
| 2023-05-05 Option Award |
2023-05-09 6:14 pm |
2024-05-05 2033-05-05 |
HALOZYME THERAPEUTICS INC. | HALO | Daly James M Director |
19,436 | $0 | 51,874 (Direct) |
View |
| 2023-05-05 Option Award |
2023-05-09 6:12 pm |
2024-05-05 2033-05-05 |
HALOZYME THERAPEUTICS INC. | HALO | Connaughton Bernadette Director |
19,436 | $0 | 51,657 (Direct) |
View |
| 2023-05-05 Option Award |
2023-05-09 6:09 pm |
2024-05-05 2033-05-05 |
HALOZYME THERAPEUTICS INC. | HALO | BIZZARI JEAN-PIERRE Director |
19,436 | $0 | 78,186 (Direct) |
View |
| 2023-04-18 Exercise |
2023-04-19 6:07 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $18.41 | 169,416 (Direct) |
View |
| 2023-04-18 Exercise |
2023-04-19 6:07 pm |
N/A 2028-02-14 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
10,000 | $0 | 169,416 (Direct) |
View |
| 2023-02-27 Exercise(A) |
2023-04-19 6:01 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
2,984 | $18.41 | 179,416 (Direct) |
View |
| 2023-02-27 Exercise(A) |
2023-04-19 6:01 pm |
N/A 2028-02-14 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
2,984 | $0 | 179,416 (Direct) |
View |
| 2023-03-07 Exercise |
2023-03-09 5:04 pm |
N/A 2024-01-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $14.66 | 653,666 (Direct) |
View |
| 2023-03-01 Gift |
2023-03-01 6:11 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
10,000 | $0 | 623,666 (Direct) |
View |
| 2023-02-16 Exercise |
2023-02-21 7:05 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
6,112 | $0 | 233,165 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 7:05 pm |
2024-02-16 2033-02-16 |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
65,902 | $0 | 233,165 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 7:02 pm |
2024-02-16 2033-02-16 |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL |
74,139 | $0 | 74,139 (Direct) |
View |
| 2023-02-16 Exercise |
2023-02-21 7:00 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
5,094 | $0 | 106,722 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 7:00 pm |
2024-02-16 2033-02-16 |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
82,377 | $0 | 106,722 (Direct) |
View |
| 2023-02-16 Exercise |
2023-02-21 6:59 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
21,010 | $0 | 957,552 (Direct) |
View |
| 2023-02-16 Option Award |
2023-02-21 6:59 pm |
2024-02-16 2033-02-16 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
260,859 | $0 | 957,552 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-17 06:29 am |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
1,170 | $49.2 | 152,465 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-17 06:29 am |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
3,386 | $0 | 152,465 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-17 06:25 am |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
621 | $49.2 | 9,005 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-17 06:25 am |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
1,254 | $0 | 9,005 (Direct) |
View |
| 2023-02-15 Tax Withholding |
2023-02-17 06:20 am |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
6,892 | $49.2 | 649,901 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-17 06:20 am |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
13,092 | $0 | 649,901 (Direct) |
View |
| 2023-02-10 Tax Withholding |
2023-02-14 5:24 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
5,676 | $48.92 | 161,610 (Direct) |
View |
| 2023-02-10 Exercise |
2023-02-14 5:24 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER |
16,016 | $0 | 161,610 (Direct) |
View |
| 2023-02-10 Tax Withholding |
2023-02-14 5:21 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
2,073 | $48.92 | 8,366 (Direct) |
View |
| 2023-02-10 Exercise |
2023-02-14 5:21 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | LaBrosse Nicole SVP, CHIEF FINANCIAL OFFICER |
3,892 | $0 | 8,366 (Direct) |
View |
| 2023-02-10 Tax Withholding |
2023-02-14 5:17 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
33,735 | $48.92 | 648,798 (Direct) |
View |
| 2023-02-10 Exercise |
2023-02-14 5:17 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
64,075 | $0 | 648,798 (Direct) |
View |
| 2023-02-07 Exercise |
2023-02-09 5:44 pm |
N/A 2024-01-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $14.66 | 707,177 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:06 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Duncan Barbara Gayle Director |
1,188 | $0 | 1,188 (Direct) |
View |
| 2023-01-17 Exercise |
2023-01-19 5:07 pm |
N/A 2024-01-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $14.66 | 797,177 (Direct) |
View |
| 2023-01-03 Tax Withholding |
2023-01-04 6:00 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL |
2,804 | $55.13 | 27,640 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-04 6:00 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Snyder Mark Howard SVP, GENERAL COUNSEL |
7,611 | $0 | 27,640 (Direct) |
View |
| 2022-12-13 Exercise |
2022-12-15 7:12 pm |
N/A 2024-01-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $14.66 | 887,177 (Direct) |
View |
| 2022-11-16 Gift |
2022-11-17 5:11 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | MATSUI CONNIE Director |
9,250 | $0 | 178,939 (Direct) |
View |
| 2022-11-16 Gift |
2022-11-17 5:10 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Connaughton Bernadette Director |
5,998 | $0 | 32,221 (Direct) |
View |
| 2022-11-15 Exercise |
2022-11-17 5:09 pm |
N/A 2024-01-06 |
HALOZYME THERAPEUTICS INC. | HALO | Torley Helen PRESIDENT AND CEO |
30,000 | $14.66 | 977,177 (Direct) |
View |
| 2022-05-05 Option Award |
2022-05-06 8:07 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Posard Matthew L. Director |
6,206 | $0 | 135,189 (Direct) |
View |
| 2022-05-05 Option Award |
2022-05-06 8:07 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | Miyashita Akiko Moni Director |
6,206 | $0 | 6,206 (Direct) |
View |
| 2022-05-05 Option Award |
2022-05-06 8:06 pm |
N/A N/A |
HALOZYME THERAPEUTICS INC. | HALO | MATSUI CONNIE Director |
6,206 | $0 | 188,189 (Direct) |
View |